The relocation is helped in part by Grow NJ tax credits of up to US$32 million approved by the New Jersey Economic Development Authority (NJEDA). “With this move, Modern Meadow is committed to expanding its biofabrication platform and continuing to build next-generation materials for the consumers of the future. We are thrilled to be in close proximity to a scientific talent pool and look forward to growing with Nutley”, said Andras Forgacs, CEO, Modern Meadow.

Founded in 2011, the biotech company aims at re-imagining animal materials, such as leather, by applying design and engineering to biology. With US$53.5 million total funding to date, and the new 72,900 sq ft space to expand, Modern Meadow says it is hiring and planning to add 200 new employees by 2020.

During the Society of Leather Technologists and Chemists (SLTC) conference in Northampton, spokesperson for Leather Naturally and ILM columnist Mike Redwood asked David Williamson, Chief Technology Officer, Modern Meadow, for an update of the company’s future plans. Read more here. As recently reported by ILM, Williamson presented how the company uses yeast fermentation and biofabrication to produce collagen materials at a competitive cost and industrial scale at the annual meeting of the Society for Industrial Microbiology and Biotechnology (SIMB).